Two Research Triangle-based clinical research organizations stand as the top health-related companies from North Carolina making the Inc. 500.
Clinipace Worldwide ranked 279 on Inc. magazine‘s list of the 500 fastest-growing private companies. The Morrisville, North Carolina-based CRO, which has carved out a particular niche in oncology, generated 2010 revenue of $12.4 million. That figure represents a 1,170 percent increase over the previous three years. Acquisitions have figured heavily into Clinipace’s growth. The company has made three acquisitions in the last three years, including a May deal for Swiss CRO PFC Pharma Focus, an acquisition that the company said would help build Clinipace’s global footprint. Among health companies on Inc’s list, Clinipace ranks No. 20.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
A10 Clinical Solutions ranked 328 on the Inc.’s 500. The Cary, North Carolina-based CRO had 2010 revenue of $19.7 million, a 1,011 percent increase over the previous three years. A10 ranks No. 24 among health companies.
Nine North Carolina health companies ranked on Inc.’s list of the 5,000 fastest-growing private companies. They are:
- Prodigy Diabetes Care, No. 1209 on the Inc. 5000. The Charlotte-based company engineers, designs and manufactures medical devices for patients with diabetes. Prodigy generated $32.3 million in 2010 revenue, which represents three-year growth of 244 percent. Prodigy ranks No. 87 in the health category.
- BlueDot Medical, No. 1,664. The Charlotte company supplies medical equipment and generated $4.6 million in 2010 revenue, a three-year increase of 162 percent. BlueDot ranks No. 129 in the health category.
- TSI Healthcare, No. 1,700. TSI provides electronic medical records, practice management systems and other IT services to physicians. TSI generated $15.9 million in 2010 revenue and grew 158 percent over the previous three years.
- MedPro Rx, No. 2,654. The Raleigh company is a specialty infusion pharmacy for patients who require medications for complex, chronic conditions. MedPro reported $56.2 million in 2010 revenue, an 86 percent increase over three years ago. MedPro ranks 231 in Inc’s health category.
- Cortech Solutions, No. 2,823. The Wilmington company sells and supports systems for brain research. Cortech had $3.6 million in 2010 revenue and has grown 77 percent over the previous three years.
- MYCO Medical, No. 3,034. The Cary-based supplier of medical equipment had $9.7 million in 2010 revenue and three-year growth of 67 percent. MYCO ranks 269 in the health category.
- LipoScience, No. 3,254. The Raleigh company develops and sells diagnostic tests to count lipoproteins in the blood as a gauge of cardiovascular risk. LipoScience’s 2010 revenue was $39.4 million, a three-year increase of 59 percent. It might be LipoScience’s last time on Inc.’s list. The company filed plans for an IPO in June. LipoScience ranks No. 280 among health companies on the list.
- MedExpress Pharmacy, No. 3,417. The Salsibury company is an online, mail-order pharmacy that specializes in serving patients with chronic illnesses. The company, which ranks No. 302 in the health category, had $19 million in 2010 revenue and three-year growth of 52 percent.
- Global Medical Imaging, No. 3,858. The Charlotte company sells, services and supports ultrasound and other systems. Global Medical Imaging, No. 347 among health companies, had $20.6 million in 2010 revenue and three-year-growth of 37 percent.
